Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL918052 | 1.00 | CNR2 (0.31) | CNR2 | |
| SCHEMBL3742324 | 1.00 | CNR2 (0.31) | CNR2 | |
| SCHEMBL31069784 | 1.00 | CNR2 (0.31) | CNR2 | |
| SCHEMBL1130554 | 1.00 | CNR2 (0.31) | CNR2 | |
| SCHEMBL2549969 | 0.90 | ADRA2A (0.32) | — | |
| SCHEMBL10227022 | 0.86 | CNR2 (0.31) | CNR2 | |
| SCHEMBL25860783 | 0.86 | — | — | |
| SCHEMBL17421987 | 0.83 | CNR2 (0.30) | CNR2 | |
| SCHEMBL12172138 | 0.79 | CNR2 (0.32) | CNR2 | |
| SCHEMBL22343067 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111057080-B | Preparation method of boron-containing indolinone derivative | 浙江工业大学 | 2022-07-08 | — | — | CN | claimed |
| EP-2855419-B1 | NEW INDANYLOXYPHENYLCYCLOPROPANECARB OXYLIC ACIDS | BOEHRINGER INGELHEIM INT (DE) | 2017-03-01 | — | — | EP | claimed |
| JP-9255668-A | — | — | None | — | — | JP | disclosed |
| US-20230331690-A1 | THC DERIVATIVES, ORAL DOSAGE FORMS COMPRISING SAME, USES THEREOF FOR TREATING DISEASES AND DISORDERS AND SYNTHESIS THEREOF | EYBNA TECHNOLOGIES LTD. (IL) | 2023-10-19 | — | — | US | disclosed |
| EP-4237416-A1 | THC DERIVATIVES, ORAL DOSAGE FORMS COMPRISING SAME, USES THEREOF FOR TREATING DISEASES AND DISORDERS AND SYNTHESIS THEREOF | Bar Ilan University (IL) | 2023-09-06 | — | — | EP | disclosed |
| CN-111057080-B | Preparation method of boron-containing indolinone derivative | 浙江工业大学 | 2022-07-08 | — | — | CN | disclosed |
| WO-2022091098-A1 | THC DERIVATIVES, ORAL DOSAGE FORMS COMPRISING SAME, USES THEREOF FOR TREATING DISEASES AND DISORDERS AND SYNTHESIS THEREOF | BAR-ILAN UNIVERSITY (IL) | 2022-05-05 | — | — | WO | disclosed |
| CN-111057080-A | Preparation method of boron-containing indolinone derivative | 浙江工业大学 | 2020-04-24 | — | — | CN | disclosed |
| US-20160311791-A1 | NOVEL TRICYCLIC CALCIUM SENSING RECEPTOR ANTOGONISTS FOR THE TREATMENT OF OSTEOPOSOSIS | MERCK SHARP & DOHME CORP. (US) | 2016-10-27 | — | — | US | disclosed |
| EP-3083621-A1 | NOVEL TRICYCLIC CALCIUM SENSING RECEPTOR ANTAGONISTS | Merck Sharp & Dohme Corp. (US) | 2016-10-26 | — | — | EP | disclosed |
| WO-2015095261-A1 | NOVEL TRICYCLIC CALCIUM SENSING RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME CORP. (US) | 2015-06-25 | — | — | WO | disclosed |
| EP-1054867-B1 | ANTIVIRALS | MEDIVIR AB (SE) | 2004-04-14 | — | — | EP | disclosed |
| US-20040059138-A1 | Dihydropyrancarboxamides and uses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2004-03-25 | — | — | US | disclosed |
| US-20030119881-A1 | N-((2-hydroxy,3-(alkyloxo),6-halophenyl)-(1,2-cyclopropylene) -),N'-((5-cyano or bromo)pyrid-2-yl)urea; retroviricides; HIV reverse transcriptase inhibitors; prolonged time to virus resistance | MEDIVIR AB (SE) | 2003-06-26 | — | — | US | disclosed |
| US-6486183-B1 | Antivirals | MEDIVIR AB (SE) | 2002-11-26 | — | — | US | disclosed |
| US-20020123645-A1 | Method for producing optically active chrysanthemic acid | SUMITOMO CHEMICAL COMPANY, LIMITED | 2002-09-05 | — | — | US | disclosed |
| EP-1236708-A1 | Method for producing optically active chrysanthemic acid | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-09-04 | — | — | EP | disclosed |
| EP-1054867-A1 | ANTIVIRALS | MEDIVIR AB (SE) | 2000-11-29 | — | — | EP | disclosed |
| WO-1999036406-A1 | ANTIVIRALS | MEDIVIR AB (SE) | 1999-07-22 | — | — | WO | disclosed |
| JP-H09255668-A | PRODUCTION OF BISOXAZOLINES | SUMITOMO CHEM CO LTD | 1997-09-30 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331690-A1 | THC DERIVATIVES, ORAL DOSAGE FORMS COMPRISING SAME, USES THEREOF FOR TREATING DISEASES AND DISORDERS AND SYNTHESIS THEREOF | CNR2, CNR1, UGT1A10 | CNR2 1/4885 |
| US-20020123645-A1 | Method for producing optically active chrysanthemic acid | ENO1, CYP8B1, CRYAA | CNR2 3828/4885 |
| US-20040059138-A1 | Dihydropyrancarboxamides and uses thereof | CCNA1, DPYD, DHFR | CNR2 182/4885 |
| US-20160311791-A1 | NOVEL TRICYCLIC CALCIUM SENSING RECEPTOR ANTOGONISTS FOR THE TREATMENT OF OSTEOPOSOSIS | CASR, CALCR, CALCRL | CNR2 145/4885 |
| US-20030119881-A1 | N-((2-hydroxy,3-(alkyloxo),6-halophenyl)-(1,2-cyclopropylene) -),N'-((5-cyano or bromo)pyrid-2-yl)urea; retroviricides; HIV reverse transcriptase inhibitors; prolonged time to virus resistance | RAD1, POLL, PNPO | CNR2 479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.